Indian Journal of Critical Care Medicine

Register      Login



Volume / Issue

Online First

Related articles

VOLUME 28 , ISSUE 6 ( June, 2024 ) > List of Articles

Original Article

Incidence and Risk Factors for Deep Venous Thrombosis and Its Impact on Outcome in Patients Admitted to Medical Critical Care

Adhiti Krishnamoorthy, Samuel G Hansdak, John V Peter, Kishore Pichamuthu, Sudha J Rajan, Thomas I Sudarsan, Sridhar Gibikote, Lakshmanan Jeyaseelan, Thambu D Sudarsanam

Keywords : Cohort, Deep vein thrombosis, Intensive care unit, Mortality, Thromboprophylaxis

Citation Information : Krishnamoorthy A, Hansdak SG, Peter JV, Pichamuthu K, Rajan SJ, Sudarsan TI, Gibikote S, Jeyaseelan L, Sudarsanam TD. Incidence and Risk Factors for Deep Venous Thrombosis and Its Impact on Outcome in Patients Admitted to Medical Critical Care. Indian J Crit Care Med 2024; 28 (6):607-613.

DOI: 10.5005/jp-journals-10071-24723

License: CC BY-NC 4.0

Published Online: 31-05-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Objectives: This study evaluated the incidence and risk factors for deep venous thrombosis (DVT) while on thromboprophylaxis, in patients admitted to the medical intensive care unit (MICU), and to assess its impact on outcomes. Methods: Consecutive patients admitted to the MICU underwent compression ultrasound of the jugular, axillary, femoral, and popliteal veins at admission, day 3 and 7 to screen for DVT. All patients were on pharmacological and/or mechanical thromboprophylaxis as per protocol. The primary outcome was the incidence of DVT (defined as occurrence on day 3 or 7). Secondary outcomes were death and duration of hospitalization. Risk factors for DVT were explored using bivariate and multivariable logistic regression analysis and expressed as risk ratio (RR) with 95% confidence intervals (CIs). Results: The incidence of DVT was 17.2% (95% CI 12.0, 22.3) (n = 35/203); two-thirds were catheter associated (23/35). There was no difference in mortality between those with and without incident DVT (9/35 vs 40/168, p = 0.81). The mean (SD) duration of hospitalization was longer in the DVT group (20.1 (17) vs 12.9 (8.5) days, p = 0.007). Although day 3 INR (RR 2.1, 95% CI 0.9–5.3), age >40 years (2.1, 0.8–5.3), vasopressor use (1.0, 0.4–2.9) and SOFA score (0.9, 0.85–1.1) were associated with the development of DVT on bivariate analysis, only central venous catheters (15.97, 1.9–135.8) was independently associated with DVT on multivariable analysis. Conclusions: Despite thromboprophylaxis, 17% of ICU patients develop DVT. The central venous catheter is the main risk factor. DVT is not associated with increased mortality in the setting of prophylaxis.

PDF Share
  1. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274(4):335–337. PMID: 7609264.
  2. Geerts W, Cook D, Selby R, Etchells E. Venous thromboembolism and its prevention in critical care. In: Database of Abstracts of Reviews of Effects (DARE): Quality-Assessed Reviews [Internet]. Centre for Reviews and Dissemination (UK); 2002. Accessed April 19, 2024. Available from:
  3. Cook D, Crowther M, Meade M, Rabbat C, Griffith L, Schiff D, et al. Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med 2005;33(7):1565–1571. DOI: 10.1097/01.ccm.0000171207.95319.b2.
  4. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of postoperative deep-vein thrombosis. Lancet Lond Engl 1969;2(7614):230–232. DOI: 10.1016/s0140-6736(69)90002-6.
  5. Geerts W, Selby R. Prevention of venous thromboembolism in the ICU. Chest 2003;124(6 Suppl):357S–363S. DOI: 10.1378/chest.124.6_suppl.357s.
  6. McLeod AG, Geerts W. Venous thromboembolism prophylaxis in critically ill patients. Crit Care Clin 2011;27(4):765–780. v. DOI: 10.1016/j.ccc.2011.07.001.
  7. Jagiasi BG, Chhallani AA, Dixit SB, Kumar R, Pandit RA, Govil D, et al. Indian Society of Critical Care Medicine Consensus Statement for Prevention of Venous Thromboembolism in the Critical Care Unit. Indian J Crit Care Med 2022;26(Suppl 2):S51–S65. DOI: 10.5005/jp-journals-10071-24195.
  8. Ho KM, Chavan S, Pilcher D. Omission of early thromboprophylaxis and mortality in critically ill patients: A multicenter registry study. Chest 2011;140(6):1436–1446. DOI: 10.1378/chest.11-1444.
  9. Sud S, Mittmann N, Cook DJ, Geerts W, Chan B, Dodek P, et al. Screening and prevention of venous thromboembolism in critically ill patients: A decision analysis and economic evaluation. Am J Respir Crit Care Med 2011;184(11):1289–1298. DOI: 10.1164/rccm.201106-1059OC.
  10. Pandey A, Patni N, Singh M, Guleria R. Assessment of risk and prophylaxis for deep vein thrombosis and pulmonary embolism in medically ill patients during their early days of hospital stay at a tertiary care center in a developing country. Vasc Health Risk Manag 2009;5:643–648. DOI: 10.2147/vhrm.s6416.
  11. Sharma SK, Gupta V, Kadhiravan T, Banga A, Seith A, Kumar A, et al. A prospective study of risk factor profile and incidence of deep venous thrombosis among medically-ill hospitalized patients at a tertiary care hospital in northern India. Indian J Med Res 2009;130(6):726–730. PMID: 20090134.
  12. Ramakrishnan N, Detect-Dvt Investigators. Prophylaxis and incidence of symptomatic deep vein thrombosis in Indian patients with sepsis: DETECT-deep vein thrombosis registry. Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med 2017;21(11):765–771. DOI: 10.4103/ijccm.IJCCM_205_17.
  13. Kumar A, Mehta Y, Ali T, Gupta MK, George JV. Deep vein thrombosis in medical and surgical intensive care unit patients in a tertiary care centre in North India: Incidence and risk factors. J Anaesthesiol Clin Pharmacol 2017;33(2):181–186. DOI: 10.4103/0970-9185.209760.
  14. Liew NC, Chang YH, Choi G, Chu PH, Gao X, Gibbs H, et al. Asian venous thromboembolism guidelines: Prevention of venous thromboembolism. Int Angiol 2012;31(6):501–516. PMID: 23222928.
  15. Mehta Y, Chaudhry D, Abraham OC, Chacko J, Divatia J, Jagiasi B, et al. Critical Care for COVID-19 Affected Patients: Updated Position Statement of the Indian Society of Critical Care Medicine. Indian J Crit Care Med 2020;24(Suppl 5):S225–S230. DOI: 10.5005/jp-journals-10071-23621.
  16. Fernando SM, Tran A, Cheng W, Sadeghirad B, Arabi YM, Cook DJ, et al. VTE Prophylaxis in Critically Ill Adults: A Systematic Review and Network Meta-analysis. Chest 2022;161(2):418–428. DOI: 10.1016/j.chest.2021.08.050.
  17. Angral R, Islam MS, Kundan S. Incidence of deep vein thrombosis and justification of chemoprophylaxis in Indian patients: A prospective study. Bangladesh Med Res Counc Bull 2012;38(2):67–71. DOI: 10.3329/bmrcb.v38i2.12885.
  18. Xu XF, Yang YH, Zhai ZG, Liu S, Zhu GF, Li CS, et al. [Prevalence and incidence of deep venous thrombosis among patients in medical intensive care unit]. Zhonghua Liu Xing Bing Xue Za Zhi 2008;29(10):1034–1037. PMID: 19173891.
  19. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton 3rd LJ. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160(6):809–815. DOI: 10.1001/archinte.160.6.809.
  20. Lee AD, Stephen E, Agarwal S, Premkumar P. Venous thrombo-embolism in India. Eur J Vasc Endovasc Surg Off J Eur Soc Vasc Surg 2009;37(4):482–485. DOI: 10.1016/j.ejvs.2008.11.031.
  21. Ansari K, Dalal K, Patel M. Risk stratification and utilisation of thrombo-embolism prophylaxis in a medical-surgical ICU: A hospital-based study. J Indian Med Assoc 2007;105(9):536, 538:540. PMID: 18338482.
  22. Palkar AV, Karnik ND. Risk stratification, prevalence by hand-held microdoppler and in-hospital mortality of deep venous thrombosis in indoor geriatric population. J Assoc Physicians India 2013;61(8): 539–542. PMID: 24818337.
  23. Saxena A, Mittal A, Arya SK, Malviya D, Srivastava U. Safety and efficacy of low-molecular-weight heparins in prophylaxis of deep vein thrombosis in postoperative/ICU patients: A comparative study. J Nat Sci Biol Med 2013;4(1):197–200. DOI: 10.4103/0976-9668.107290.
  24. Joynt GM, Li TS, Griffith JF, Gomersall CD, Yap FH, Ho AM, et al. The incidence of deep venous thrombosis in Chinese medical Intensive Care Unit patients. Hong Kong Med J 2009;15(1):24–30. PMID: 19197093.
  25. Panitchote A, Chaiyasoot W, Permpikul C. Prevalence and incidence of proximal deep vein thrombosis in critically ill patients. Crit Care 2010;14(Suppl 1):P359. DOI: 10.1186/cc8591.
  26. Adimi Naghan P, Malekmohammad M, Jamaati H, Sharifkashani B, Najafi A, Hashemian SM. Venous thromboembolism in medical critically ill patients: Prevalence and incidence. Acta Med Iran 2013;51(3):168–171. PMID: 23605601.
  27. Cook D, Attia J, Weaver B, McDonald E, Meade M, Crowther M. Venous thromboembolic disease: An observational study in medical-surgical intensive care unit patients. J Crit Care 2000;15(4):127–132. DOI: 10.1053/jcrc.2000.19224.
  28. Velmahos GC, Nigro J, Tatevossian R, Murray JA, Cornwell EE, Belzberg H, et al. Inability of an aggressive policy of thromboprophylaxis to prevent deep venous thrombosis (DVT) in critically injured patients: Are current methods of DVT prophylaxis insufficient. J Am Coll Surg 1998;187(5):529–533. DOI: 10.1016/s1072-7515(98)00223-3.
  29. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. CHEST J 1997;1:111(3):661–664. DOI: 10.1378/chest.111.3.661.
  30. Ibrahim EH, Iregui M, Prentice D, Sherman G, Kollef MH, Shannon W. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 2002;30(4):771–774. DOI: 10.1097/00003246-200204000-00008.
  31. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Deep vein thrombosis (DVT) free steering Committee. Upper-extremity deep vein thrombosis: A prospective registry of 592 patients. Circulation 2004;110(12): 1605–1611. DOI:
  32. Malinoski DJ, Ewing T, Patel MS, Nguyen D, Le T, Cui E, et al. The natural history of upper extremity deep venous thromboses in critically ill surgical and trauma patients: What is the role of anticoagulation. J Trauma 2011;71(2):316–321; discussion 321–322. DOI: 10.1097/TA.0b013e318222f3f4.
  33. Lamontagne F, McIntyre L, Dodek P, Heels-Ansdell D, Meade M, Pemberton J, et al. Nonleg venous thrombosis in critically ill adults: A nested prospective cohort study. JAMA Intern Med 2014;174(5): 689–696. DOI: 10.1001/jamainternmed.2014.169.
  34. PROTECT Investigators for the Canadian Critical Care Trials Group and the Australian and New Zealand Intensive Care Society Clinical Trials Group, Cook D, Meade M, Guyatt G, Walter S, Heels-Ansdell D, et al. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011;364(14):1305–1314. DOI: 10.1056/NEJMoa 1014475.
  35. Cook D, Meade M, Guyatt G, Griffith L, Granton J, Geerts W, et al. Clinically important deep vein thrombosis in the intensive care unit: A survey of intensivists. Crit Care 2004;8(3):R145–R152. DOI: 10.1186/cc2859.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.